Эстония - эстонский - Ravimiamet

first pharma oÜ - tolterodiin - õhukese polümeerikattega tablett - 2mg 56tk; 2mg 28tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - tolterodiin - toimeainet prolongeeritult vabastav kõvakapsel - 4mg 7tk; 4mg 84tk; 4mg 200tk; 4mg 100tk; 4mg 98tk; 4mg 28tk; 4mg 14tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - tolterodiin - õhukese polümeerikattega tablett - 2mg 28tk; 2mg 56tk

Эстония - эстонский - Ravimiamet

sandoz pharmaceuticals d.d. - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 84tk; 500mg 60tk; 500mg 112tk

Эстония - эстонский - Ravimiamet

norameda uab - abirateroon - õhukese polümeerikattega tablett - 500mg 60tk; 500mg 56tk

Эстония - эстонский - Ravimiamet

sandoz pharmaceuticals d.d. - abirateroon - õhukese polümeerikattega tablett - 1000mg 56tk; 1000mg 84tk; 1000mg 28tk; 1000mg 30tk; 1000mg 60tk

Эстония - эстонский - Ravimiamet

g.l. pharma gmbh - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk

Европейский союз - эстонский - EMA (European Medicines Agency)

mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Европейский союз - эстонский - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Эстония - эстонский - Ravimiamet

zentiva k.s. - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk